These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37857898)

  • 41. Venlafaxine: a heterocyclic antidepressant.
    Ellingrod VL; Perry PJ
    Am J Hosp Pharm; 1994 Dec; 51(24):3033-46. PubMed ID: 7856622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder.
    Perry R; Cassagnol M
    Clin Ther; 2009 Jun; 31 Pt 1():1374-404. PubMed ID: 19698900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI.
    Sigurdsson HP; Hefner G; Ben-Omar N; Köstlbacher A; Wenzel-Seifert K; Hiemke C; Haen E
    J Neural Transm (Vienna); 2015 May; 122(5):721-9. PubMed ID: 25257248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
    Lobello KW; Preskorn SH; Guico-Pabia CJ; Jiang Q; Paul J; Nichols AI; Patroneva A; Ninan PT
    J Clin Psychiatry; 2010 Nov; 71(11):1482-7. PubMed ID: 20441720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
    Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
    Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.
    Men X; Taylor ZL; Marshe VS; Blumberger DM; Karp JF; Kennedy JL; Lenze EJ; Reynolds CF; Stefan C; Mulsant BH; Ramsey LB; Müller DJ
    Clin Pharmacol Ther; 2024 May; 115(5):1065-1074. PubMed ID: 38284409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.
    Unterecker S; Reif A; Hempel S; Proft F; Riederer P; Deckert J; Pfuhlmann B
    Int Clin Psychopharmacol; 2014 Jul; 29(4):206-11. PubMed ID: 24374906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Venlafaxine plus melatonin ameliorate reserpine-induced depression-like behavior in zebrafish.
    Tang YQ; Li ZR; Zhang SZ; Mi P; Chen DY; Feng XZ
    Neurotoxicol Teratol; 2019; 76():106835. PubMed ID: 31518687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venlafaxine for neuropathic pain in adults.
    Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions.
    Unterecker S; Hiemke C; Greiner C; Haen E; Jabs B; Deckert J; Pfuhlmann B
    Pharmacopsychiatry; 2012 Sep; 45(6):229-35. PubMed ID: 22426847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.
    Launiainen T; Rasanen I; Vuori E; Ojanperä I
    Int J Legal Med; 2011 May; 125(3):349-58. PubMed ID: 20432045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
    Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
    Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis.
    Oliva V; Possidente C; De Prisco M; Fico G; Anmella G; Hidalgo-Mazzei D; Murru A; Fanelli G; Fabbri C; Fornaro M; de Bartolomeis A; Solmi M; Radua J; Vieta E; Serretti A
    Lancet Psychiatry; 2024 Mar; 11(3):210-220. PubMed ID: 38360024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacotherapy for social anxiety disorder (SAnD).
    Williams T; Hattingh CJ; Kariuki CM; Tromp SA; van Balkom AJ; Ipser JC; Stein DJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001206. PubMed ID: 29048739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
    Nichols AI; Lobello K; Guico-Pabia CJ; Paul J; Preskorn SH
    J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
    Vinetti M; Haufroid V; Capron A; Classen JF; Marchandise S; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):865-9. PubMed ID: 22077251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.